IndraLab

Statements

Cholesterol inhibits KCNQ1. 1 / 1

| 1

reach

"In the present study, we investigated the effects of three cholesterol lowering agents (probucol, an enhancer of cholesterol efflux; simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor; and triparanol, a 3beta-hydroxysterol-^ 24-reductase inhibitor) on cholesterol synthesis, the KCNQ1 current (I KCNQ1), and the I (Ks) to clarify the differences in the modes of action of these agents on the I (Ks)."

23424208

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Cholesterol inhibits KCNQ1. 1 / 1

INDRA sources:

Databases

Reading